Interdisciplinary Symposium on Osteoporosis (ISO) Cancelled »

| NOF in the News, Osteoporosis in the News

  Dear Attendees, We hope that you, your family and colleagues are safe and healthy during this unprecedented COVID-19 pandemic. All staff at the National Osteoporosis Foundation (NOF) are working from home, but fully able to continue to serve our patient and healthcare professional communities. After careful consideration, we have decided to cancel the Interdisciplinary… Read more »

NOF Statement on Access to Osteoporosis Medications Covered Under Medicare Part B During COVID-19 Pandemic »

| Advocacy, NOF in the News, Osteoporosis in the News

Contact: Claire Gill, Interim CEO claire.gill@nof.org The National Osteoporosis Foundation (NOF), the country’s leading health organization representing 10 million Americans who suffer from osteoporosis, a chronic disease that weakens bone and increases a person’s risk for debilitating and deadly fractures, urges Members of Congress to assure that patients who are covered by Medicare Part B… Read more »

UPDATED: Coronavirus: What Older Adults Need to Know »

| Osteoporosis in the News

By Kathleen Cameron, BSPharm, MPH | 2.28.2020 Note: This blog post was originally published by the National Council on Aging and was updated on March 7 with the latest information from the Centers for Disease Control (CDC). Please check back frequently for updates and visit CDC for the most current news. The situation around the novel coronavirus (COVID-19)… Read more »

May is National Osteoporosis Month »

| NOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation (NOF) launches new resources including interactive digital tool, podcast and first-of-its-kind patient registry in honor of 35th Anniversary ARLINGTON, VA (April 22, 2019) — NOF is celebrating National Osteoporosis Month in May and its 35th Anniversary with the launch of new resources designed to help people of all ages understand the… Read more »

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture »

| NOF in the News, Osteoporosis in the News, Press Releases

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS,… Read more »

Bindex Measurement Revolutionizes Osteoporosis Diagnostics in US »

| Osteoporosis in the News

Bone Index Ltd., a medical device company with game-changing point-of-care technology (Bindex®) in osteoporosis diagnostics, announces that one million patients have been measured with Bindex® in the U.S. in 2018. Earlier this year, the American Medical Association issued a new reimbursement code* for Bindex® and the Centers for Medicare & Medicaid Services (CMS) has approved… Read more »

NPR Article: Wider Use Of Osteoporosis Drug Could Prevent Bone Fractures In More Elderly Women »

| NOF in the News, Osteoporosis in the News

In response to a recent NPR article detailing the positive results of a common osteoporosis drug, Elizabeth Thompson, NOF, CEO, said:  “When the experts in the field say that this study is “extremely important”, “highly effective”, and “a breakthrough”, we are making progress! Reducing suffering and maintaining life quality is important for our senior population—key… Read more »